Report
Valens Research

EL - Embedded Expectations Analysis - 2021 01 26

The Estée Lauder Companies Inc. (EL:USA) currently trades at a historical high relative to UAFRS-based (Uniform) earnings, with a 40.0x Uniform P/E, implying bullish expectations for the firm. However, management may have concerns about their growth in Asian markets, the sustainability of Asian and mature client consumption, and their online business

Specifically, management may lack confidence in their ability to sustain growth and recovery in Asian markets, as well as maintain their Chinese consumption levels. Management may also be exaggerating the importance of market specialization in Korea's fragrance market and the sustainability of hair care demand and innovation. Furthermore, they may lack confidence in their ability to offer better online services that will attract new consumers, maintain the strong performance of their Estée Lauder and La Mer brands in Asia, and sustain the performance of their body and home fragrances. Moreover, they may have concerns about the pace of the economic recovery in the U.S. and Europe, the sustainability of their mature consumer demographic spending, and the timeline for a return of international travel traffic
Underlying
Estee Lauder Companies Inc. Class A

Estee Lauder Companies is a manufacturer and marketer of skin care, makeup, fragrance and hair care products. The company's products are sold under a number of brand names including: Estee Lauder, Clinique, Origins, MzAzC, Bobbi Brown, La Mer, Jo Malone London, Aveda and Too Faced. The company is also the global licensee for fragrances, cosmetics and/or related products sold under various designer brand names. The company's products include skin care, makeup and related items such as compacts, brushes and other makeup tools, fragrance sold in various forms, hair care, and other ancillary products and services.

Provider
Valens Research
Valens Research

In 2009, just as the dust was settling from the last major equity and credit market crises, we launched a boutique research firm with the intention of breaking Wall Street’s biases and broken incentives:

  • GAAP and IFRS have failed to provide rules for reliable financial statement reporting
  • Stock analyst recommendations are not grounded in disciplined financial analysis
  • Credit agencies have been set up to grossly fail in their responsibilities to investors and the public markets
  • Utter lack of willingness of major research firms to employ the the most advanced forensic analysis available

We sought to provide investors and company analysts with a source of information that changed all that.
Many years later, our business model remains because little has changed on Wall Street.

  • Corporate credit ratings remain years behind the fundamental underpinnings of company performance
  • Stock analysts continue to make recommendations with deeply inherent biases
  • Research firms have failed to break down the walls between credit, equity, and macroeconomic research
  • The governing accounting bodies have created more leeway for mis-estimates and mis-classifications as financials have become unwieldy and overwhelming

The integrity of Valens Research is founded in our disciplined processes and analytics. No “star” analysts. No corporate advisory relationships. No-nonsense opinions and recommendations.

Analysts
Valens Research

Other Reports on these Companies
Other Reports from Valens Research

ResearchPool Subscriptions

Get the most out of your insights

Get in touch